Evidence map›Paper›PMID 42524099›Full record

ReviewRSC advances2026

Failure mechanisms in redox flow batteries: from apparent capacity decay to active-material loss.

Zirui Li, Zitong Wang, Sirou Li, Jianing Xie, Xiaomin Wang

Abstract readReview
In one paragraph

Review in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zirui LiXinjiang Key Laboratory of Novel Functional Materials Chemistry, College of Chemistry and Environmental Science, Kashi University Kashi 844000 Xinjiang PR China ty.com.cn@126.com.
Zitong WangXinjiang Key Laboratory of Novel Functional Materials Chemistry, College of Chemistry and Environmental Science, Kashi University Kashi 844000 Xinjiang PR China ty.com.cn@126.com.
Sirou LiXinjiang Key Laboratory of Novel Functional Materials Chemistry, College of Chemistry and Environmental Science, Kashi University Kashi 844000 Xinjiang PR China ty.com.cn@126.com.
Jianing XieXinjiang Key Laboratory of Novel Functional Materials Chemistry, College of Chemistry and Environmental Science, Kashi University Kashi 844000 Xinjiang PR China ty.com.cn@126.com.ORCID https://orcid.org/0009-0009-1291-7290
Xiaomin WangXinjiang Key Laboratory of Novel Functional Materials Chemistry, College of Chemistry and Environmental Science, Kashi University Kashi 844000 Xinjiang PR China ty.com.cn@126.com.ORCID https://orcid.org/0009-0005-8202-0789

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Redox flow batteries (RFBs) are promising for long-duration energy storage, but their capacity decay is often a system-level consequence of coupled crossover, electrolyte imbalance, chemical degradation, interfacial deterioration, deposition instability, and operating-condition perturbations. A major challenge in lifetime diagnosis is that observable capacity loss does not always correspond to irreversible active-material loss; in many cases, it first reflects recoverable imbalance or redistribution of active species. This review introduces the concept of the dominant degradation boundary to identify the constraint that first establishes a persistent capacity limitation under a given chemistry and operating window and that controls the subsequent transition from apparent capacity decay to true active-material loss. Using a boundary-amplification-conversion framework, the degradation pathways of all-vanadium, iron-chromium, zinc-bromine, and organic redox flow batteries are compared. The analysis shows that different RFB chemistries exhibit distinct front-end boundaries, amplification processes, recoverability windows, and true-loss pathways. This framework provides a diagnostic basis for distinguishing recoverable and irreversible capacity decay, comparing degradation behavior across chemistries, and prioritizing mitigation strategies for lifetime extension.

Identifiers

PMID42524099
PMCPMC13409848

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.